| View |
|
DRP-12734
|
5% Dextrose in Water
|
Nir-5D
|
5 g per 100mL (5%w/v)
|
Solution for IV Infusion
|
-
|
Aculife Healthcare Private Limited
|
India
|
PCPR Conversion
|
29 September 2022
|
29 May 2026
|
| View |
|
DRP-12733
|
Lactated Ringer's Solution
|
NIR-RL
|
(see reverse for formulation)
|
Solution for I.V. Infusion
|
-
|
Aculife Healthcare Private Limited
|
India
|
PCPR Conversion
|
29 September 2022
|
14 October 2026
|
| View |
|
DRP-12732
|
5% Dextrose In 0.9% Sodium Chloride
|
NIR-DNS
|
Solution For Intravenous Infusion (See Reverse for Formulation Details)
|
|
-
|
Aculife Halthcare Private Limited
|
India
|
PCPR Conversion
|
29 September 2022
|
24 May 2027
|
| View |
|
DRP-12728
|
Meropenem (as trihydrate)
|
Meroqure-5
|
500 mg
|
Powder for Injection (I.V.)
|
-
|
Swiss Parenterals Ltd
|
India
|
PCPR Conversion
|
29 September 2022
|
19 February 2026
|
| View |
|
DRP-12729
|
Meropenem (as Trihydrate)
|
Meroqure-10
|
1 g
|
Powder for Injection (I.V.)
|
-
|
Swiss Parenterals Ltd
|
India
|
PCPR Conversion
|
29 September 2022
|
22 March 2027
|
| View |
|
DRP-5930-04
|
Omeprazole Sodium
|
Donprazole
|
40 mg
|
Lyophilized Powder for Injection
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
27 October 2023
|
05 December 2028
|
| View |
|
DRP-8263-09
|
Mupirocin
|
Mupirv
|
20 mg/ g (2% w/w)
|
Ointment
|
Antibacterial
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Renewal
|
19 June 2024
|
10 July 2029
|
| View |
|
DRP-9637-05
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pitazovin
|
4 g/500 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 September 2022
|
23 April 2026
|
| View |
|
DRP-9975-07
|
Cefuroxime(as axetil)
|
Nicoxime
|
500 mg
|
Film-Coated Tablet
|
Antibacterial(Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
28 September 2022
|
01 July 2026
|
| View |
|
DRP-10199-06
|
Trimetazidine Hydrochloride
|
Gotazidine
|
35 mg
|
Modified Release Tablet
|
Anti-angina
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
28 September 2022
|
04 August 2026
|
| View |
|
DRP-10240-02
|
Multivitamins + Dexpanthenol
|
Sannovit
|
(see reverse for formulation)
|
Solution for Injection IM/IV
|
Vitamins
|
Kwality Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
28 September 2022
|
21 July 2025
|
| View |
|
DRP-10630-04
|
Vancomycin (as hydrochloride)
|
None
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial (Glycopeptide)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
28 September 2022
|
10 November 2026
|
| View |
|
DRP-11154-17
|
Nicardipine
|
None
|
1mg/mL (10mg/10mL)
|
Solution For Injection (Iv Infusion)
|
Calcium Channel Blocker (Dihydropiridine derivative)
|
MAKCUR LABORATORIES LIMITED
|
India
|
Automatic Renewal
|
28 September 2022
|
11 February 2027
|
| View |
|
DRP-11456-01
|
Telmisartan + Amlodipine
|
Mistacor AM
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker - Calcium Channel Blocker combination
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 September 2022
|
16 March 2027
|
| View |
|
DRP-11591-01
|
Bupivacaine Hydrochloride
|
Sergivell Plain
|
5 mg/ mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
-
|
HBM Pharma S.R.O
|
Slovak Republic
|
CLIDP Conversion
|
28 September 2022
|
01 April 2027
|
| View |
|
DRP-11661-04
|
Propofol
|
Profmax
|
10 mg/mL
|
Emulsion for injection (I.V.)
|
General Anesthetic
|
Daewon Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
28 September 2022
|
07 April 2027
|
| View |
|
DRP-12213-02
|
Cefuroxime (as axetil)
|
Vispoxetil
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
NGB Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 September 2022
|
13 July 2027
|
| View |
|
DRP-12239-02
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Biokast
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
28 September 2022
|
07 July 2027
|
| View |
|
DRP-12323-01
|
Telmisartan
|
Mezartel-40
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Macter International Ltd.
|
Pakistan
|
CLIDP Conversion
|
28 September 2022
|
30 June 2026
|
| View |
|
DRP-12382-02
|
Sodium Bicarbonate
|
Qodic
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.)
|
Electrolyte Solutions
|
Jeil Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
28 September 2022
|
29 July 2027
|